Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents.

@article{Schulz2010PlateletRT,
  title={Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents.},
  author={Stefanie R Schulz and Dirk Sibbing and Sigmund Lorenz Braun and Tanja Morath and Julinda Mehilli and Steffen Massberg and Robert A. Byrne and Albert Schoemig and Adnan Kastrati},
  journal={American heart journal},
  year={2010},
  volume={160 2},
  pages={355-61}
}
BACKGROUND Preclinical studies suggest a relationship between early thrombotic response after vascular injury and later development of restenosis. The aim of this study was to assess the impact of platelet response to clopidogrel on the risk of restenosis after drug-eluting stenting (DES). METHODS A total of 1,608 consecutive patients were previously enrolled in a study on the relation between platelet reactivity and outcomes after DES. All patients received a loading dose of 600 mg… CONTINUE READING